Jan 06, 2026 15:32
ARWR - Arrowhead Research Corporation
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 38.2 2.1 (5.5%) | 0.0 (0.0%) | 0.04 (0.11%) | 0.36 (0.9%) | -0.17 (-0.45%) | 2.29 (6.02%) | -0.01 (-0.03%) | 0.22 (0.58%) |
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- -1.26
- Diluted EPS:
- -1.26
- Basic P/E:
- -31.9841
- Diluted P/E:
- -31.9841
- RSI(14) 1m:
- 71.28
- VWAP:
- 40.24
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Jan 09, 2025 18:00
Apr 04, 2024 11:23
Mar 11, 2024 14:37
Mar 01, 2024 16:18
Feb 07, 2024 17:01
Jan 04, 2024 15:12
Jan 03, 2024 17:58
Jan 03, 2024 15:24
Jan 02, 2024 20:00